These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28072524)

  • 21. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
    Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Definitive Pharmacophore Modelling Study on CDK2 ATP Pocket Binders: Tracing the Path of New Virtual High-Throughput Screenings.
    Tutone M; Culletta G; Livecchi L; Almerico AM
    Curr Drug Discov Technol; 2020; 17(5):740-747. PubMed ID: 31250757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance.
    Karaboga AS; Planesas JM; Petronin F; Teixidó J; Souchet M; Pérez-Nueno VI
    J Chem Inf Model; 2013 May; 53(5):1043-56. PubMed ID: 23577723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S; Schneider G
    J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
    Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
    J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
    Chaudhuri A; Hudait N; Chakraborty SS
    Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies.
    Lone MY; Manhas A; Athar M; Jha PC
    J Biomol Struct Dyn; 2018 Aug; 36(11):2951-2965. PubMed ID: 28849732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
    Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
    Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations.
    Wieder M; Perricone U; Seidel T; Boresch S; Langer T
    Monatsh Chem; 2016; 147():553-563. PubMed ID: 27069282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophore modeling and structure-based virtual screening to identify potent inhibitors targeting LuxP of Vibrio harveyi.
    Rajamanikandan S; Srinivasan P
    J Recept Signal Transduct Res; 2016 Dec; 36(6):617-632. PubMed ID: 27049472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
    Ahmadi M; Nowroozi A; Shahlaei M
    J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening.
    Tran-Nguyen VK; Da Silva F; Bret G; Rognan D
    J Chem Inf Model; 2019 Jan; 59(1):573-585. PubMed ID: 30563339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.
    Kumar SP
    J Mol Model; 2018 Sep; 24(10):282. PubMed ID: 30220049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AutoPH4: An Automated Method for Generating Pharmacophore Models from Protein Binding Pockets.
    Jiang S; Feher M; Williams C; Cole B; Shaw DE
    J Chem Inf Model; 2020 Sep; 60(9):4326-4338. PubMed ID: 32639159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
    Vuorinen A; Schuster D
    Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.
    Qing XY; Zhang CH; Li LL; Ji P; Ma S; Wan HL; Wang ZR; Zou J; Yang SY
    J Biomol Struct Dyn; 2013; 31(2):215-23. PubMed ID: 22831459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements for potential HIV-integrase inhibitors identified using pharmacophore-based virtual screening and molecular dynamics studies.
    Islam MA; Pillay TS
    Mol Biosyst; 2016 Mar; 12(3):982-93. PubMed ID: 26809073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.